Wedbush Increases Chelsea Therapeutics International Price Target to $8.00 (CHTP)
Stock analysts at Wedbush raised their price target on shares of Chelsea Therapeutics International (NASDAQ:CHTP) from $7.00 to $8.00 in a report issued on Thursday, AnalystRatingsNetwork.com reports. The firm currently has an “outperform” rating on the stock. Wedbush’s target price indicates a potential upside of 183.69% from the company’s current price.
Chelsea Therapeutics International (NASDAQ:CHTP) traded up 6.02% on Thursday, hitting $2.82. 1,545,997 shares of the company’s stock traded hands. Chelsea Therapeutics International has a 52-week low of $0.73 and a 52-week high of $3.30. The stock’s 50-day moving average is $3.0 and its 200-day moving average is $2.45. The company’s market cap is $189.4 million.
Separately, analysts at Ladenburg Thalmann raised their price target on shares of Chelsea Therapeutics International from $3.50 to $4.00 in a research note to investors on Thursday, September 5th. They now have a “buy” rating on the stock.
Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.